Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the National Prostate Cancer Audit's report entitled NPCA State of the Nation Report 2024, published January 2025, what steps he is taking to tackle inequalities preventing Black men from (a) receiving early diagnosis and (b) accessing NICE recommended treatments following advanced prostate cancer diagnosis.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
To address disparities and find ways to better detect prostate cancer earlier, we have invested £16 million in the United Kingdom-wide TRANSFORM trial, aimed at helping find the best ways of detecting prostate cancer in men, even if they are not displaying any symptoms. This research will aim to address some of the inequalities that exist in prostate cancer diagnosis by targeting black men in trial recruitment, ensuring that one in ten participants are black men.
Following publication of the 10-Year Health Plan, we will publish a new National Cancer Plan, which will include further details on how we will improve access to treatments and outcomes for all tumour types, including prostate cancer. We are now in discussions about what form that plan should take, and what its relationship to the 10-Year Health Plan and the Government’s wider Health Mission should be. We will provide updates on this in due course.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make it his policy to set a target of reducing overall cancer mortality in the UK by 15% by 2040.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
Professor Lord Darzi’s report set out that the United Kingdom has higher mortality from cancer than neighbouring countries, the Nordic countries, and other English-speaking countries, using data published by the Organisation for Economic Co-operation and Development.
The Government’s Health Mission sets the objective of building a National Health Service fit for the future and reducing lives lost to the biggest killers, including cancer. We have launched a 10-Year Health Plan to reform the NHS and make it fit for the future. The plan will set out a bold agenda to deliver on the three big shifts needed to move healthcare from hospital to the community, analogue to digital, sickness to prevention and will be co-designed with the public, staff, and patients.
My rt. Hon. Friend, the Secretary of State for Health and Social Care, has been clear that there should be a National Cancer Plan. The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, by speeding up diagnosis and treatment and ensuring patients have access to the latest treatments and technology. We are now in discussions about what form that Plan should take, what the overarching goal should be, and what its relationship to the 10-Year Health Plan and the Government’s wider Health Mission should be.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of NHS preparedness for the next generation of blood cancer treatments.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
We are committed to implementing the recommendations of the Lord O'Shaughnessy review into commercial clinical trials, to ensure that innovative, lifesaving treatments are accessible to National Health Service patients, including those with blood cancer.
The Government has also stated that £70 million will be spent on new radiotherapy machines, which will help ensure that the most advanced treatment is available to patients who need it.
In September 2024, Lord Darzi concluded an immediate and independent investigation of the NHS. These findings will help to support improvements across the healthcare system, including through the new 10-Year Health Plan. A core part of this will be our workforce, including the cancer workforce, and how we ensure we train and provide the staff, technology, and infrastructure the NHS needs to care for patients across our communities.
In addition, we will develop a new national cancer plan, which will include further details on how we will improve outcomes for cancer patients, including blood cancer.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he plans to take to tackle (a) delays to diagnosis and (b) emergency presentation rates for blood cancer patients.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon. Member to the answer I gave to the Hon. Member for Sutton and Cheam on 2 December 2024 to Question 16329.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of blood donation rules on iron levels on the number of Black, Asian and Minority Ethnic women unable to donate blood.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS Blood and Transplant (NHSBT) tests for haemoglobin levels rather than iron levels ahead of blood donation. If the test shows that the haemoglobin is low, the donor is deferred and information is provided on how they can increase haemoglobin levels through altering their diet, and book an appointment with their general practitioner if levels are particularly low. On average, 7% to 11% of donors are deferred because of low haemoglobin levels, but this rises to 12% of black heritage donors and to 25% of female black heritage donors. These deferrals impact on donor retention, as donors deferred for low haemoglobin are less likely to return.
Currently there are no plans to review minimum haemoglobin levels to donate blood. Donors whose haemoglobin levels are below safe levels to donate are deferred in accordance with the Blood Safety and Quality Regulations 2005 and the guidance issued by the Joint UK Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC) which states ‘taking a donation from a person with a haemoglobin concentration below the recommended value may make them anaemic’.
Increasing diversity in the donor base is a priority for NHSBT, so they can provide matched blood for more patients, including those with rare blood types commonly found in black, Asian, and minority ethnic women. NHSBT provides grants to community and faith groups to encourage donation, including in black, Asian, and minority ethnic communicates. The Department provided seed funding for NHSBT to increase its collection capacity, particularly in diverse areas where higher proportions of the population have rare blood types, including Brixton and Brighton.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of blood donation rules on (a) iron levels in and (b) the adequacy of the supply of rare blood types commonly found in Black, Asian and Minority Ethnic women.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS Blood and Transplant (NHSBT) tests for haemoglobin levels rather than iron levels ahead of blood donation. If the test shows that the haemoglobin is low, the donor is deferred and information is provided on how they can increase haemoglobin levels through altering their diet, and book an appointment with their general practitioner if levels are particularly low. On average, 7% to 11% of donors are deferred because of low haemoglobin levels, but this rises to 12% of black heritage donors and to 25% of female black heritage donors. These deferrals impact on donor retention, as donors deferred for low haemoglobin are less likely to return.
Currently there are no plans to review minimum haemoglobin levels to donate blood. Donors whose haemoglobin levels are below safe levels to donate are deferred in accordance with the Blood Safety and Quality Regulations 2005 and the guidance issued by the Joint UK Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC) which states ‘taking a donation from a person with a haemoglobin concentration below the recommended value may make them anaemic’.
Increasing diversity in the donor base is a priority for NHSBT, so they can provide matched blood for more patients, including those with rare blood types commonly found in black, Asian, and minority ethnic women. NHSBT provides grants to community and faith groups to encourage donation, including in black, Asian, and minority ethnic communicates. The Department provided seed funding for NHSBT to increase its collection capacity, particularly in diverse areas where higher proportions of the population have rare blood types, including Brixton and Brighton.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reviewing the minimum iron level required to donate blood.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS Blood and Transplant (NHSBT) tests for haemoglobin levels rather than iron levels ahead of blood donation. If the test shows that the haemoglobin is low, the donor is deferred and information is provided on how they can increase haemoglobin levels through altering their diet, and book an appointment with their general practitioner if levels are particularly low. On average, 7% to 11% of donors are deferred because of low haemoglobin levels, but this rises to 12% of black heritage donors and to 25% of female black heritage donors. These deferrals impact on donor retention, as donors deferred for low haemoglobin are less likely to return.
Currently there are no plans to review minimum haemoglobin levels to donate blood. Donors whose haemoglobin levels are below safe levels to donate are deferred in accordance with the Blood Safety and Quality Regulations 2005 and the guidance issued by the Joint UK Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee (JPAC) which states ‘taking a donation from a person with a haemoglobin concentration below the recommended value may make them anaemic’.
Increasing diversity in the donor base is a priority for NHSBT, so they can provide matched blood for more patients, including those with rare blood types commonly found in black, Asian, and minority ethnic women. NHSBT provides grants to community and faith groups to encourage donation, including in black, Asian, and minority ethnic communicates. The Department provided seed funding for NHSBT to increase its collection capacity, particularly in diverse areas where higher proportions of the population have rare blood types, including Brixton and Brighton.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of patients unable to secure appointments with their GP due to (a) digital exclusion and (b) lack of telephone access.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
General practices (GPs) and other National Health Service organisations are encouraged to support patients to use online routes where this would be convenient for them, and there is work to improve the usability of digital tools so that they are accessible to larger numbers of patients. However, a choice of access routes should remain available.
As outlined in the GP Contract, digital services should be provided in addition to other channels for accessing GPs, such as in person visits, rather than as a replacement. Practice receptions should also remain open to ensure that those without access to a telephone or online services are not disadvantaged.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the Maternity Disparities Taskforce is still active; how many meetings of that taskforce have taken place since it was established; and if he will publish the (a) dates and (b) durations of those meetings.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Maternity Disparities Taskforce is not currently active, having met six times on: 8 March 2022, 16 May 2022, 18 July 2022, 18 April 2023, 5 September 2023 and 31 January 2024. The duration of these meetings were approximately an hour and a half.
It is a priority for the Government to make sure all women and babies receive the high-quality care they deserve, regardless of their background or ethnicity. The Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health, Baroness Merron, is considering the immediate action needed to tackle inequalities for women and babies and racism in maternity services; including what targets are needed.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to support Start for Life services in Lambeth; and if he will extend the funding of such services beyond 1 April 2025.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The Family Hubs and Start for Life programme is central to delivering the Government’s commitments to give every baby the best start in life, and to deliver the healthiest generation of children ever. Lambeth is one of 75 local authorities the Government is funding to ensure parents and carers can access Start for Life services, from conception to the age of two years old.
We work closely with Lambeth to support programme implementation across all funded strands, and they have opened six Family Hub sites with Start for Life services at their heart since 2023. We also signpost policy toolkits, provide guidance, and facilitate the sharing of good practice between local authorities.
The Autumn Budget announcement included £69 million to continue delivery of a network of Family Hubs in 2025/26. The Department will confirm Start for Life funding in due course.